VDAC1 and acute kidney injury: Inhibition of GSK3β blocks phosphorylation of VDAC1, attenuates mitochondrial permeability transition, reduces mitochondrial dysfunction and oxidative stress, and ameliorates oxidant-induced AKI [27].